Watch CBSN Live

Pfizer submits COVID-19 vaccine trial data to FDA for children aged 5-11

Pfizer and BioNTech announced they have submitted results to the U.S. Food and Drug Administration from their coronavirus vaccine trial on children aged 5 to 11. According to a statement, the results showed a "favorable safety profile." Dr. William Schaffner, a professor of infectious diseases at Vanderbilt University Medical Center, joined CBSN to discuss.
View CBS News In
CBS News App Open
Chrome Safari Continue
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.